Bafna Pharmaceuticals share news and announcements
NSE: BAFNAPHBSE: 532989Pharmaceuticals & BiotechnologySmall Cap
Last close ₹442.95down ₹9.00 (1.99%)BSE ₹449.85
Share price at the NSE close on 23 Oct 2026. Previous close ₹451.95.
52-week range of traded prices to 23 Oct 2026
₹94.77Low, 16 Mar 2026₹479.95High, 21 Oct 2026
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹1,048 Cr2,105th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 11 Aug 2026
- 134.6
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 29 May 2026
- 10.9
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 11 Aug 2026
- 8.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 11 Aug 2026
- 4.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 29 May 2026
- 0.39
- Volume, NSEVolume. Shares traded on the last trading day.
- 1,422
Bafna Pharmaceuticals share news and announcements
637 announcements, routine notices left out, newest first. Page 12 of 13.
Mar 2013
5 Mar · "RARICAP" Brand Assignment / Registration in favour of Bafna Pharmaceuticals Ltd
Feb 2013
11 Feb · Limited Review for Dec 31, 2012
1 Feb · Board meeting
Among the others to consider the Un-Audited Financial Results for the quarter ending December 31, 2012
Dec 2012
27 Dec · Board meeting
Nov 2012
Sep 2012
27 Sep · Meeting
The 17th Annual General Meeting (AGM) of the Company was held on September 27, 2012 and all the resolutions as per the notice dated August ....18 Sep · Board meeting
Board of Directors of the Company at its meeting held on September 15, 2012, Inter alia, has approved the following: 1. Allotted ....13 Sep · Board Meeting on Sep 15, 2012
Meeting of the Board of Directors of the Company will be held on September 15, 2012, inter alia, to consider Allotment of Shares pursuant ....
Aug 2012
31 Aug · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from September 22, 2012 to September 27, 2012 (both days ....16 Aug · Board meeting
Board of Directors of the Company at its meeting held on August 14, 2012, inter alia, has allotted 1,25,000 Equity Shares pursuant to ....9 Aug · Board Meeting on Aug 14, 2012
Meeting of the Board of Directors of the Company will be held on August 14, 2012 inter alia, to consider : 1. The Un-Audited Financial ....
May 2012
30 May · Board meeting
Board of Directors of the Company at its meeting held on May 30, 2012, inter alia, has : 1. Decided to conserve the reserves hence ....28 May · Board Meeting Postponed on May 30, 2012
Board Meeting scheduled to be held on May 28, 2012 has been postponed to May 30, 2012 due to unavoidable circumstances inter alia: ....24 May · Board meeting
Meeting of the Board of Directors of the Company will be held on May 28, 2012, inter alia 1. To approve Audited Financial Results ....
Apr 2012
27 Apr · Results
Company opted to submit audited financial results for the entire financial year within sixty days of end of the financial year ending ....
Mar 2012
Feb 2012
13 Feb · Revised Limited Review for Dec 31, 2011
10 Feb · Board meeting
Board of Directors of the Company at its meeting held on February 10, 2012, inter alia, has transacted the following: - Proposed ....
Jan 2012
20 Jan · Meeting
Extra Ordinary General Meeting (EGM) of the Company will be held on February 22, 2012, for the purpose of ratifying the Item No. 6 of ....13 Jan · Board meeting
Board of Directors of the Company at its meeting held on January 13, 2012, inter alia, has approved the following; 1. Approved ....12 Jan · Updates on Board Meeting on Jan 13, 2012
With reference to earlier announcement dated January 10, 2012 regarding Board Meeting on Jan 13, 2012, Bafna Pharmaceuticals Ltd has now informed BSE that, pursuant to in-Principle approval ....10 Jan · Board Meeting on Jan 13, 2012
Meeting of the Board of Directors of the Company will be held on January 13, 2012, inter alia, to consider the revised facilities offered ....
Nov 2011
Sep 2011
3 Sep · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from September 21, 2011 to September 23, 2011 (both days ....
Aug 2011
25 Aug · Board meeting
Board of Directors of the Company at its meeting held on August 24, 2011, inter alia, has transact the following: 1. The Board ....18 Aug · Board Meeting on Aug 24, 2011
Meeting of the Board of Directors of the Company will be held on August 24, 2011, inter alia, to consider: 1. The withdrawal of ....2 Aug · Updates on subsidiary Company
M/s. Bafna Lifestyles Remedies Ltd. has been subsidiary of the Company in accordance with the provisions of the Companies Act, 1956.
Jul 2011
Jun 2011
2 Jun · Board Meeting on Jun 07, 2011
Meeting of the Board of Directors of the Company will be held on June 07, 2011, inter alia, to consider increase of authorized capital ....
May 2011
11 May · Results
Company opts to submit audited financial results for the entire financial year within sixty days of end of the financial year ending March 31, 2011.
Apr 2011
6 Apr · Acquired the Brand "RARICAP"
With reference to the earlier announcement dated March 22, 2011, regarding acquisition of "RARICAP" brand, Bafna Pharmaceuticals Ltd has now informed BSE that on April 06, 2011 the Company ....
Mar 2011
22 Mar · Business
On March 22, 2011, the Company has signed an agreement with NR Jet, an affiliate of Johnson & Johnson Limited, for acquisition of the TradeMark ....17 Mar · Board meeting
Board of Directors of the Company at its meeting held on March 17, 2011, has allotted 15,00,000 Equity Shares of Rs. 10/- each at a premium ....